How do you diagnose insulin resistance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Insulin Resistance

The most effective way to diagnose insulin resistance is through a combination of clinical risk assessment and laboratory testing, including fasting plasma glucose, fasting insulin levels, oral glucose tolerance test, and hemoglobin A1C. 1

Clinical Risk Assessment

  • Evaluate for risk factors that predispose to insulin resistance:
    • Overweight or obesity (BMI ≥25 kg/m² or ≥23 kg/m² in Asian Americans) 1
    • Family history of type 2 diabetes 1
    • Racial/ethnic predisposition (American Indian, African American, Hispanic, or Asian/Pacific Islander) 1
    • Physical signs including acanthosis nigricans (dark, velvety skin patches typically in body folds), hypertension, dyslipidemia, or polycystic ovary syndrome 1

Laboratory Diagnostic Tests

Primary Tests

  • Fasting plasma glucose (FPG):

    • Values between 100-125 mg/dL indicate impaired fasting glucose, suggesting insulin resistance 1
    • Must be measured after at least an 8-hour fast 2
  • Fasting plasma insulin levels:

    • Normal: <15 mU/L
    • Borderline high: 15-20 mU/L
    • High: >20 mU/L (directly suggests insulin resistance) 1
  • Oral glucose tolerance test (OGTT):

    • 2-hour glucose values of 140-199 mg/dL indicate impaired glucose tolerance, suggesting insulin resistance 1
    • Involves administering 75g of glucose and measuring blood glucose after 2 hours 2
  • Hemoglobin A1C:

    • Values between 5.7-6.4% suggest prediabetes and potential insulin resistance 1, 2

Supplementary Tests

  • C-peptide measurement:

    • Helps differentiate between endogenous insulin production and exogenous insulin administration 1
    • Simultaneous elevation of insulin and C-peptide suggests endogenous hyperinsulinism, indicating insulin resistance 1
  • Lipid profile:

    • Elevated triglycerides (>150 mg/dL) and low HDL cholesterol (<40 mg/dL in men, <50 mg/dL in women) often accompany insulin resistance 1

Calculation-Based Methods

  • Homeostasis Model Assessment of Insulin Resistance (HOMA-IR):

    • Formula: (Fasting insulin [μU/mL] × Fasting glucose [mg/dL])/405
    • Values >2.5 suggest insulin resistance 3, 4
  • TyG Index (Triglycerides-Glucose Index):

    • Formula: Ln[fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2]
    • Can be useful when insulin testing is unavailable 5

Physical Examination

  • Check for:
    • Acanthosis nigricans (particularly on the neck, axillae, and groin) 1
    • Central obesity (waist circumference >40 inches in men or >35 inches in women) 1
    • Blood pressure (>130/85 mmHg suggests metabolic syndrome) 1

Common Pitfalls to Avoid

  • Testing should be performed in the fasting state to avoid postprandial variations that can affect results 1
  • Medications that affect glucose metabolism should be noted when interpreting results 1
  • Stress hyperglycemia during acute illness can temporarily mimic insulin resistance and should not be used for diagnosis 1
  • Isolated elevated C-peptide without hypoglycemia generally reflects insulin resistance rather than pathological hyperinsulinism 1
  • Relying on a single test without confirmation can lead to misdiagnosis 2

Diagnostic Algorithm

  1. Identify patients with risk factors for insulin resistance
  2. Perform fasting laboratory tests (glucose, insulin, lipid profile)
  3. If fasting glucose is 100-125 mg/dL or fasting insulin is >15 mU/L, insulin resistance is likely 1
  4. Consider OGTT if fasting tests are borderline or normal but clinical suspicion remains high 1
  5. Calculate HOMA-IR if both fasting glucose and insulin are available 3, 4
  6. If insulin testing is unavailable, consider using the TyG index as an alternative 5

References

Guideline

Diagnosing Insulin Resistance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis of Type 2 Diabetes Mellitus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How can we measure insulin sensitivity/resistance?

Diabetes & metabolism, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.